Brief: Camurus Announces PDUFA Date For Brixadi NDA For The Treatment Of Opioid Use Disorder In The US
08/12/2022 22:02
Dec 8 (Reuters) - Camurus AB CAMX.ST :
* CAMURUS ANNOUNCES PDUFA DATE FOR BRIXADI™ NDA FOR THE
TREATMENT
OF OPIOID USE DISORDER IN THE US
* NEW PRESCRIPTION DRUG USER FEE ACT (PDUFA) ACTION DATE IS
SET
FOR 23 MAY 2023
Source text for Eikon: ID:nWkr9NGbjH
Further company coverage: CAMX.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Camurus AB
See all newsBrief: Camurus Receives Approval In Canada For Oczyesa XR
Brief: Executive Sells About £279,000 Of Camurus Shares
Jefferies cuts Ipsen to 'underperform' on Somatuline competition risk
Brief: Camurus Says NDA Resubmission For CAM2029 In Acromegaly Accepted For Review By FDA
Camurus shares rise after Q2 revenue, operating profit beat